News and Announcements
Market Cap of Zelwin hits $120 000 000 USD
- Published July 12, 2020 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Eleven teams have worked on this powerful project Zelwin.com – Global Marketplace of Goods, including developers, designers, sales specialists, programmers, blockchain technology specialists, lawyers, economists, PR specialists and marketers, HR specialists, e-commerce specialists and many others.
In May, Zelwin listed on Coinsbit.io exchange and BitForex.com in the TOP-20. Also, Korean Probit.com named Zelwin as one of the strongest projects in recent years.
These exchanges valued Zelwin’s project & digital assets at $150- $300 million at the time of listing and they are confident that capitalisation can be increased to $1 billion this year.
The price in started at 1 dollar for one ZELWIN token. But now, on Coinmarketcap, the price for Zelwin tokens are more than 3$ and we’re growing.
It means that early investors received more than 225%+ of ROI.
About ZELWIN.com – Global Marketplace of Goods
Online trading platform ZELWIN where combined digital assets and e-commerce.
A huge advantage of this platform that for every purchase, customers get guaranteed cashback in ZLW tokens. They instantly be able to exchange these tokens for various cryptocurrencies, USD/EUR, send them to VISA/MasterCard or save them up.
In addition, it’s ready-made product with a clear business model and with a mass adoption.
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
